FR2864426A1 - Food supplement designed to make up for nutritional deficiencies comprises paste matrix with added extracts of fruit, vegetable or animal origin, vitamins and minerals - Google Patents
Food supplement designed to make up for nutritional deficiencies comprises paste matrix with added extracts of fruit, vegetable or animal origin, vitamins and minerals Download PDFInfo
- Publication number
- FR2864426A1 FR2864426A1 FR0315534A FR0315534A FR2864426A1 FR 2864426 A1 FR2864426 A1 FR 2864426A1 FR 0315534 A FR0315534 A FR 0315534A FR 0315534 A FR0315534 A FR 0315534A FR 2864426 A1 FR2864426 A1 FR 2864426A1
- Authority
- FR
- France
- Prior art keywords
- food
- ingredients
- agent
- food supplement
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 45
- 239000000284 extract Substances 0.000 title claims abstract description 20
- 239000011159 matrix material Substances 0.000 title claims abstract description 16
- 229940088594 vitamin Drugs 0.000 title claims abstract description 11
- 239000011782 vitamin Substances 0.000 title claims abstract description 11
- 235000013399 edible fruits Nutrition 0.000 title claims abstract description 10
- 229930003231 vitamin Natural products 0.000 title claims abstract description 10
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 9
- 239000011707 mineral Substances 0.000 title claims abstract description 9
- 241001465754 Metazoa Species 0.000 title claims abstract description 6
- 235000013311 vegetables Nutrition 0.000 title claims abstract description 6
- 208000002720 Malnutrition Diseases 0.000 title description 4
- 235000018343 nutrient deficiency Nutrition 0.000 title description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 11
- 239000003349 gelling agent Substances 0.000 claims abstract description 10
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 235000016709 nutrition Nutrition 0.000 claims abstract description 9
- 150000002632 lipids Chemical class 0.000 claims abstract description 8
- 235000010755 mineral Nutrition 0.000 claims abstract description 8
- 235000015097 nutrients Nutrition 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 6
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 4
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 4
- 239000003381 stabilizer Substances 0.000 claims abstract description 4
- 239000003765 sweetening agent Substances 0.000 claims abstract description 4
- 239000003085 diluting agent Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 22
- 235000011837 pasties Nutrition 0.000 claims description 14
- 239000013589 supplement Substances 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 claims description 11
- 230000007170 pathology Effects 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 235000002864 food coloring agent Nutrition 0.000 claims description 3
- 239000000576 food coloring agent Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 229940068517 fruit extracts Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001766 physiological effect Effects 0.000 abstract description 4
- 239000000047 product Substances 0.000 abstract description 4
- 238000000576 coating method Methods 0.000 abstract description 2
- 238000004040 coloring Methods 0.000 abstract 1
- 235000019264 food flavour enhancer Nutrition 0.000 abstract 1
- 235000021374 legumes Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 230000007423 decrease Effects 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 11
- 235000006708 antioxidants Nutrition 0.000 description 11
- 230000036642 wellbeing Effects 0.000 description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 9
- 210000000845 cartilage Anatomy 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 230000002526 effect on cardiovascular system Effects 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 230000004719 natural immunity Effects 0.000 description 7
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000011701 zinc Substances 0.000 description 7
- 229910052725 zinc Inorganic materials 0.000 description 7
- 235000016068 Berberis vulgaris Nutrition 0.000 description 6
- 241000335053 Beta vulgaris Species 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 6
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 230000002180 anti-stress Effects 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- 239000008273 gelatin Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 235000011852 gelatine desserts Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 201000008482 osteoarthritis Diseases 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 235000013406 prebiotics Nutrition 0.000 description 6
- 235000019587 texture Nutrition 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 4
- 229930064664 L-arginine Natural products 0.000 description 4
- 235000014852 L-arginine Nutrition 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 208000017442 Retinal disease Diseases 0.000 description 4
- 206010038923 Retinopathy Diseases 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 4
- 244000078534 Vaccinium myrtillus Species 0.000 description 4
- 229930003779 Vitamin B12 Natural products 0.000 description 4
- 230000001857 anti-mycotic effect Effects 0.000 description 4
- 239000002543 antimycotic Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 235000011649 selenium Nutrition 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 230000002792 vascular Effects 0.000 description 4
- 235000019163 vitamin B12 Nutrition 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- 235000019158 vitamin B6 Nutrition 0.000 description 4
- 239000011726 vitamin B6 Substances 0.000 description 4
- 229940011671 vitamin b6 Drugs 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 240000007817 Olea europaea Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 229930003537 Vitamin B3 Natural products 0.000 description 3
- 229930003761 Vitamin B9 Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 235000012721 chromium Nutrition 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 3
- 229960002442 glucosamine Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- -1 macro-elements Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 235000019160 vitamin B3 Nutrition 0.000 description 3
- 239000011708 vitamin B3 Substances 0.000 description 3
- 235000019159 vitamin B9 Nutrition 0.000 description 3
- 239000011727 vitamin B9 Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 2
- 235000010591 Appio Nutrition 0.000 description 2
- 240000004160 Capsicum annuum Species 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 244000228088 Cola acuminata Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 208000002705 Glucose Intolerance Diseases 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 241000219774 Griffonia Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 240000005428 Pistacia lentiscus Species 0.000 description 2
- 241000508269 Psidium Species 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 240000006909 Tilia x europaea Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000000489 anti-atherogenic effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008355 cartilage degradation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 229940035936 ubiquinone Drugs 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000298715 Actinidia chinensis Species 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 102000009133 Arylsulfatases Human genes 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 240000006432 Carica papaya Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 235000015438 Cola nitida Nutrition 0.000 description 1
- 102000000503 Collagen Type II Human genes 0.000 description 1
- 108010041390 Collagen Type II Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- 244000304337 Cuminum cyminum Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- 244000019459 Cynara cardunculus Species 0.000 description 1
- 235000019106 Cynara scolymus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 102000003982 Parathyroid hormone Human genes 0.000 description 1
- 108090000445 Parathyroid hormone Proteins 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000004768 Pistacia lentiscus Nutrition 0.000 description 1
- 229920000175 Pistacia lentiscus Polymers 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 244000151637 Sambucus canadensis Species 0.000 description 1
- 235000018735 Sambucus canadensis Nutrition 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127218 antiplatelet drug Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- 235000016520 artichoke thistle Nutrition 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000007123 blue elder Nutrition 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000009142 chromium supplementation Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 235000007124 elderberry Nutrition 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229940087603 grape seed extract Drugs 0.000 description 1
- 235000002532 grape seed extract Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000021579 juice concentrates Nutrition 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000004335 litholrubine BK Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 208000021722 neuropathic pain Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003349 osteoarthritic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000000199 parathyroid hormone Substances 0.000 description 1
- 229960001319 parathyroid hormone Drugs 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229940007115 shark cartilage extract Drugs 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000001717 vitis vinifera seed extract Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
Complément alimentaire destiné à combler les déficits nutritionnels Food supplement to fill nutritional deficits
La présente invention concerne un complément alimentaire permettant de corriger les déficiences nutritionnelles associées à de nombreuses pathologies, et de réduire les facteurs de risque d'évolution ou de complication de la pathologie. The present invention relates to a dietary supplement to correct the nutritional deficiencies associated with many pathologies, and to reduce the risk factors for progression or complication of the pathology.
Les compléments alimentaires peuvent être définis comme des denrées alimentaires dont le but est de supplémenter le régime alimentaire normal et qui constituent une source concentrée de nutriments ou d'autres substances ayant un effet nutritionnel et/ou physiologique. Ces compléments qui sont généralement commercialisés sous forme de doses, à savoir, les formes de présentation telles que les gélules, les pastilles, les comprimés, les pilules et d'autres formes similaires, ainsi io que les sachets de poudre, les ampoules de liquide, les flacons munis de compte gouttes et les autres formes analogues de préparations liquides ou en poudre destinées à être prises en unités mesurées de faible quantité. Les compléments alimentaires sont disponibles par l'intermédiaire de différentes sources commerciales, comprenant les magasins diététiques, les épiceries, les pharmacies etc.. L'un des premiers compléments alimentaires était sous forme d'un comprimé ou d'une gélule de multi- vitamines et minéraux, disponible en pharmacie. Les compléments alimentaires les plus répandus comprennent des vitamines, des minéraux, des nutriments ou d'autres substances ayant un effet nutritionel ou physiologique d'origine synthétique, ou naturelle, animale, ou végétale. Food supplements may be defined as foods intended to supplement the normal diet and as a concentrated source of nutrients or other substances with a nutritional and / or physiological effect. These supplements, which are generally marketed in the form of doses, namely, forms of presentation such as capsules, lozenges, tablets, pills and other similar forms, as well as sachets of powder, ampoules of liquid drop-filled vials and other similar forms of liquid or powder preparations intended to be taken in measured units of small quantity. Dietary supplements are available through various commercial sources, including health food stores, grocery stores, pharmacies etc. One of the first dietary supplements was in the form of a multi-vitamin tablet or capsule. and minerals, available in pharmacies. The most common food supplements include vitamins, minerals, nutrients or other substances with a nutritional or physiological effect of synthetic origin, or natural, animal, or plant.
Les compléments alimentaires sont principalement utilisés pour la perte de poids (25%), le bien-être (45%) et la beauté (25%). Du fait de restrictions réglementaires, les utilisations relatives à des maladies (prévention, traitement ou cure) ne sont pas autorisées, même si la plupart des produits comprennent des éléments ayant une activité pharmacologique confirmée. Dietary supplements are mainly used for weight loss (25%), well-being (45%) and beauty (25%). Due to regulatory restrictions, disease-related uses (prevention, treatment or cure) are not permitted, even though most products include elements with confirmed pharmacological activity.
Selon les règlements communautaires les compléments alimentaires peuvent faire état de trois catégories d'allégations:nutritionnelles, fonctionnelles et relative à la réduction d'un risque de maladie ( allégation relative à la santé). Il est donc possible de se référer à un bénéfice général, la conservation d'une bonne santé, le bien-être général et une fonction corporelle normale, à une amélioration d'une fonction physiologique au-delà de ce qui peut être attendu de l'alimentation seule, ou à la réduction de facteurs à risque impliqués dans le développement d'une maladie. According to EU regulations, dietary supplements may include three categories of claims: nutritional, functional and relating to the reduction of a disease risk (health claim). It is therefore possible to refer to a general benefit, the preservation of good health, general well-being and a normal bodily function, to an improvement of a physiological function beyond what can be expected from diet alone, or the reduction of risk factors involved in the development of a disease.
Selon le règlement international en vigueur, les compléments alimentaires peuvent comprendre des plantes, provenant d'une ou plusieurs sources, car les plantes sont connues pour leur activité phytothérapeutique. Ils peuvent également comprendre des agents nutritifs tels que des vitamines et/ou des minéraux. According to the current international regulation, food supplements may include plants, from one or more sources, because the plants are known for their phytotherapeutic activity. They may also include nutrients such as vitamins and / or minerals.
s La demande EP 1 355 540 décrit un complément alimentaire avec un effet amincissant, qui renforce le muscle squelettique et protège l'appareil cardiovasculaire, les composants dudit complément étant les suivants Lcarnitine propionyl, coenzyme Qlo, nicotinamide, riboflavine et acide pantothénique. The application EP 1 355 540 discloses a dietary supplement with a slimming effect, which strengthens the skeletal muscle and protects the cardiovascular system, the components of said complement being as follows Lcarnitine propionyl, coenzyme Qlo, nicotinamide, riboflavin and pantothenic acid.
Le brevet FR 2 747 017 a pour objet un complément alimentaire destiné à assurer et développer un apport optimal des substances naturelles dont a besoin un organisme en bonne santé, à la fois au niveau de la peau et de l'organisme en général. Le complément décrit dans cette référence contient des extraits naturels de fruits et légumes suivants: figue, orange amère, citron vert, limette, carotte, persil, céleri, fenouil, tomate, panais. Patent FR 2,747,017 relates to a dietary supplement for ensuring and developing an optimal intake of natural substances needed by a body in good health, both in the skin and the body in general. The supplement described in this reference contains the following natural fruit and vegetable extracts: fig, bitter orange, lime, lime, carrot, parsley, celery, fennel, tomato, parsnip.
La demande WO 02 054 890 a pour objet un complément alimentaire pour maintenir et améliorer la bonne santé de la peau, comprenant les composés suivants: lycopène, caroténoïdes, biotine, chrome et sélénium. The application WO 02 054 890 relates to a dietary supplement for maintaining and improving the health of the skin, comprising the following compounds: lycopene, carotenoids, biotin, chromium and selenium.
La demande US 2002 172 724 a pour objet une composition permettant de réduire le risque de perte de densité osseuse, comprenant notamment un composé 20 de calcium et de l'inuline, sous une forme diététiquement acceptable. The application US 2002 172 724 relates to a composition for reducing the risk of loss of bone density, including in particular a calcium compound and inulin, in a dietetically acceptable form.
Les maladies organiques sont habituellement accompagnées d'une déficience métabolique. Elles sont traitées par des médications spécifiques et des mesures d'accompagnement appropriées. Organic diseases are usually accompanied by a metabolic deficiency. They are treated with specific medications and appropriate accompanying measures.
Ainsi, les états pré-diabétiques et les diabètes de type II sont traités avec une variété d'agents pharmacologiques destinés à réduire les niveaux de sucre dans le sang ou la résistance à l'insuline. Des thérapies métaboliques sont utilisées lorsque des anomalies significatives de la glycémie sont détectées et des agents antiagrégants sont couramment prescrits pour retarder un début de la complication vasculaire du diabète au niveau de la rétine ou rétinopathie. Habituellement, un régime est également conseillé, mais n'est pas toujours bien suivi. Thus, pre-diabetic states and type II diabetes are treated with a variety of pharmacological agents to reduce blood sugar levels or insulin resistance. Metabolic therapies are used when significant abnormalities in blood glucose are detected and antiplatelet agents are commonly prescribed to delay an onset of the vascular complication of diabetes in the retina or retinopathy. Usually, a diet is also advised, but is not always well followed.
Les déficits en vitamines et minéraux présents chez le sujet prédiabétique ou diabétique ne sont en général ni recherchés, ni palliés par la prescription médicale. Les moyens permettant d'améliorer l'équilibre général de l'organisme et ainsi le bien-être à court et long terme sont aussi trop souvent négligés. Pourtant, il est rapporté dans la littérature qu'une multitude de facteurs peuvent contribuer, à l'installation de complications dans les états diabétiques. Ainsi, plusieurs études démontrent qu'une supplémentation en chrome peut améliorer le contrôle du taux de sucre circulant (glycémie) chez le diabétique. Une déficience en magnésium interrompt la sécrétion d'insuline par le pancréas et augmente la résistance à l'insuline dans les tissus du corps, contribuant ainsi à certaines complications de diabète. Le zinc est connu pour protéger de l'oxydation la protéine SPI, constitutive du gène qui code pour l'insuline. Ainsi, il exerce une action protectrice sur l'insuline. Le sélénium, un anti-oxydant puissant, a également un effet inhibiteur de l'agrégation des plaquettes sanguines, io cellules jouant un rôle dans la génération des complications vasculaires. La vitamine E contribue à diminuer la rétinopathie diabétique (définie ci-dessus) et la vitamine C est active dans la prévention de la rétinopathie et de la cataracte. Deficits in vitamins and minerals present in the prediabetic or diabetic subject are generally neither sought nor palliated by the medical prescription. The means to improve the general balance of the body and thus the well-being in the short and long term are also too often neglected. Yet, it is reported in the literature that a multitude of factors can contribute to the establishment of complications in diabetic states. Thus, several studies show that chromium supplementation can improve the control of circulating blood sugar (glycemia) in diabetics. A deficiency in magnesium interrupts insulin secretion by the pancreas and increases insulin resistance in body tissues, contributing to some diabetes complications. Zinc is known to protect the protein SPI, constitutive of the gene that codes for insulin, from oxidation. Thus, it exerts a protective action on insulin. Selenium, a potent antioxidant, also has an inhibitory effect on platelet aggregation, cells that play a role in the generation of vascular complications. Vitamin E helps to decrease diabetic retinopathy (defined above) and vitamin C is active in the prevention of retinopathy and cataracts.
L'arthrose est la plus fréquente des maladies rhumatismales chroniques. Divers facteurs peuvent être mis en cause dans son apparition, tels que l'âge, l'obésité, les facteurs génétiques etc... L'arthrose est habituellement traitée à l'aide de médicaments anti-inflammatoires afin de diminuer la douleur et les signes de l'inflammation. Osteoarthritis is the most common chronic rheumatic disease. Various factors can be implicated in its appearance, such as age, obesity, genetic factors etc ... Osteoarthritis is usually treated with anti-inflammatory drugs to reduce pain and pain. signs of inflammation.
Les déficiences métaboliques (telle qu'une déficience en vitamines) intervenant dans la pathologie sont beaucoup moins souvent prises en considération, bien que leur accumulation participe au déséquilibre de l'organisme et constitue un risque supplémentaire pour l'évolution de la maladie et de ses complications. Metabolic deficiencies (such as vitamin deficiency) occurring in the pathology are much less often taken into account, although their accumulation contributes to the imbalance of the body and constitutes an additional risk for the evolution of the disease and its symptoms. complications.
Ainsi une déficience en sélénium peut conduire à l'inhibition de la synthèse du collagène de type Il par les chondrocytes (les cellules qui génèrent le cartilage). Une déficience en vitamine C diminue l'inhibition de l'arylsulfatase, un enzyme qui détruit les liaisons sulfates dans les glycosaminoglycanes, composants essentiels du cartilage. De même le zinc, naturellement présent dans les chondrocytes sains et la matrice extracellulaire, est diminué, en quantité, de 50% dans certaines formes de la maladie rhumatismale. De faibles niveaux de vitamine D ont été inversement corrélés avec une sévérité accrue de l'Arthrose et la perte de cartilage. Une déficience en vitamine B6 provoque une diminution de la concentration en protéoglycanes dans le cartilage, le rendant ainsi plus fragile. Thus selenium deficiency can lead to the inhibition of collagen type II synthesis by chondrocytes (the cells that generate cartilage). Vitamin C deficiency decreases the inhibition of arylsulfatase, an enzyme that breaks down sulfate bonds in glycosaminoglycans, essential components of cartilage. Similarly zinc, naturally present in healthy chondrocytes and extracellular matrix, is decreased in quantity by 50% in some forms of rheumatic disease. Low levels of vitamin D were inversely correlated with increased severity of osteoarthritis and cartilage loss. A deficiency of vitamin B6 causes a decrease in the concentration of proteoglycans in the cartilage, thus making it more fragile.
Il ressort donc de ce qui précède que les mesures d'accompagnement de certaines maladies ne sont pas toujours suffisantes pour complètement contrôler la pathologie et prévenir la génération de facteurs à risque pour diverses complications. It follows from the above that the accompanying measures of certain diseases are not always sufficient to completely control the pathology and prevent the generation of risk factors for various complications.
Les déficiences nutritionnelles habituellement associées avec ces maladies sont très rarement prises en considération: ainsi, les vitamines, minéraux, oligo-éléments et anti-oxydants présents chez un patient ne font pas partie des bilans biologiques effectués pour la majorité des maladies. The nutritional deficiencies usually associated with these diseases are very rarely taken into consideration: thus, the vitamins, minerals, trace elements and antioxidants present in a patient are not part of the biological assessments performed for the majority of diseases.
Un des buts de la présente invention est de proposer, à des professionnels de la santé et aux patients, des moyens naturels et agréables de combler leurs déficits nutritionnels liés à leur maladie, et d'optimiser les conditions de leur traitement spécifique. One of the aims of the present invention is to provide health professionals and patients with natural and pleasant means of filling their nutritional deficits related to their disease, and of optimizing the conditions of their specific treatment.
Un autre but est de préparer un complément alimentaire destiné à lo accompagner le traitement médicamenteux spécifique d'une maladie déterminée, afin de corriger les déficiences nutritionnelles liées à cette maladie, et de réduire le risque de complications et/ou d'évolution vers des complications éventuelles. Another aim is to prepare a dietary supplement intended to accompany the specific drug treatment of a specific disease, in order to correct the nutritional deficiencies related to this disease, and to reduce the risk of complications and / or progression to complications. possible.
Un autre but encore de l'invention est de préparer un complément alimentaire agissant en synergie avec un médicament destiné à traiter une maladie déterminée. Yet another object of the invention is to prepare a food supplement acting in synergy with a medicament for treating a specific disease.
Le complément alimentaire selon l'invention est caractérisé en ce qu'il comporte une matrice pâteuse à base de glucides polymérisés lui conférant une consistance gélifiée solide ou semi-solide, dans laquelle sont incorporés un ou plusieurs nutriments et/ou ingrédients ayant un effet nutritionnel et/ou physiologique. The dietary supplement according to the invention is characterized in that it comprises a pasty matrix based on polymerized carbohydrates giving it a solid or semi-solid gelled consistency, in which are incorporated one or more nutrients and / or ingredients having a nutritional effect. and / or physiological.
De manière préférée, la matrice pâteuse est à base de fructooligosaccharides lui conférant une structure filamenteuse. In a preferred manner, the pasty matrix is based on fructooligosaccharides conferring on it a filamentous structure.
Les nutriments et/ou ingrédients sont avantageusement choisis parmi des extraits d'origine végétale, fruits, légumes, plantes, et/ou d'origine animale, les vitamines, les macro-éléments, et les oligo-éléments. The nutrients and / or ingredients are advantageously chosen from extracts of plant origin, fruits, vegetables, plants, and / or of animal origin, vitamins, macro-elements, and trace elements.
Les extraits utilisés sont bruts ou purifiés et/ou correspondent à des produits de 25 synthèse autorisés dans l'alimentation humaine. The extracts used are crude or purified and / or correspond to synthetic products authorized in the human diet.
Les extraits de fruits, de légumes, et/ou de plantes correspondent notamment à des jus concentrés, de la pulpe et des extraits secs ou des poudres. Extracts of fruits, vegetables and / or plants include concentrated juices, pulp and dry extracts or powders.
Des exemples de fruits qui conviennent pour la mise en oeuvre de l'invention comprennent les fruits suivants: tomate, myrtille, cassis, sureau, orange, citron, 3o pomme, coing, poire, fraise, cerise, framboise, figue, figue de barbarie, pêche, banane, ananas, raisin, mangue, papaye, kiwi, date, mangoustan, fruit de la passion, airelle, goyave, pamplemousse, ou leurs mélanges. Examples of fruits that are suitable for the implementation of the invention include the following fruits: tomato, blueberry, blackcurrant, elderberry, orange, lemon, apple 3o, quince, pear, strawberry, cherry, raspberry, fig, prickly pear , peach, banana, pineapple, grape, mango, papaya, kiwi, date, mangosteen, passion fruit, lingonberry, guava, grapefruit, or their mixtures.
Les légumes suivants sont avantageusement utilisés: choux, carotte, ail, oignon, brocoli, artichaut, céleri, carde, champignons, épinard, fenouil, olive, pourpier, soja, ou leurs mélanges. The following vegetables are advantageously used: cabbage, carrot, garlic, onion, broccoli, artichoke, celery, card, mushrooms, spinach, fennel, olive, purslane, soya, or their mixtures.
Des plantes appropriées comprennent: curcuma, gingembre, safran, muscade, thym, romarin, cumin, piment, menthe, paprika, sauge. D'autres extraits de plantes sont choisis parmi: angélique, avoine, bambou, banaba, bardane, boswella, camomille, cordalys, echinacea, frêne, garcinia, ginseng, gingko, griffonia, kola, lithotame, margousier, mastic, myrtille, olive, ortie, peuplier, réglisse, rose, scrutellaire, shitake, silgesbeckia, thé vert, thé blanc, thé noir, violette, ou leurs mélanges. Suitable plants include: turmeric, ginger, saffron, nutmeg, thyme, rosemary, cumin, chilli, mint, paprika, sage. Other plant extracts are selected from: angelica, oats, bamboo, banaba, burdock, boswella, chamomile, cordalys, echinacea, ash, garcinia, ginseng, gingko, griffonia, cola, lithotame, neem, mastic, blueberry, olive, nettle, poplar, licorice, pink, scrutinellar, shitake, silgesbeckia, green tea, white tea, black tea, violet, or their mixtures.
Les vitamines sont choisies, en particulier, dans le groupe comprenant la vitamine A, la vitamine B1, la vitamine B2, la vitamine B3 (PP), la vitamine B5, la vitamine B6, la vitamine B9, la vitamine B12, la vitamine C, la vitamine D, la vitamine E, la vitamine K, ou leurs mélanges. Vitamins are chosen, in particular, in the group comprising vitamin A, vitamin B1, vitamin B2, vitamin B3 (PP), vitamin B5, vitamin B6, vitamin B9, vitamin B12, vitamin C , vitamin D, vitamin E, vitamin K, or their mixtures.
Les minéraux sont choisis notamment dans le groupe comprenant le calcium, le magnésium, le fer, le phosphore, le potassium, le sodium ou leurs mélanges. The minerals are chosen in particular from the group comprising calcium, magnesium, iron, phosphorus, potassium, sodium or their mixtures.
Comme oligo-éléments, on citera ceux du groupe comprenant le cuivre, le fer, l'iode, le manganèse, le sélénium, le zinc, le chrome, le molybdène, le fluor, ou leurs mélanges. As micronutrients, mention will be made of those of the group comprising copper, iron, iodine, manganese, selenium, zinc, chromium, molybdenum, fluorine, or mixtures thereof.
Les glucides sont choisis avec avantage dans le groupe comprenant les oses simples (par exemple: glucose, mannose, galactose ribose, fructose), les dérivés d'oses (par exemple: lactose, saccharose, maltose, acide glucuronique, fucose), les polyosides ( amidons, glycogène, cellulose), les hétérosides ou leurs mélanges. Carbohydrates are advantageously selected from the group consisting of simple monosaccharides (for example glucose, mannose, galactose ribose, fructose), monosaccharides (for example: lactose, sucrose, maltose, glucuronic acid, fucose), polysaccharides. (starches, glycogen, cellulose), glycosides or mixtures thereof.
Les protides sont choisis dans le groupe comprenant par les acides aminés (par exemple arginine, acide aspartique, glutamine etc.), les dérivés d'acides aminés (par exemple carnitine, ornithine, hydroxyproline, glutathion, etc...), et les protéines ou leurs mélanges ou leurs dérivés. The proteins are chosen from the group consisting of amino acids (for example arginine, aspartic acid, glutamine, etc.), amino acid derivatives (for example carnitine, ornithine, hydroxyproline, glutathione, etc.), and the proteins or their mixtures or derivatives.
Les lipides sont choisis dans le groupe comprenant par les graisses d'origine végétale ou animale, les acides gras (par exemple l'acide palmitique, stéarique, oléique, linoléique, linolénique, arachidonique), les alcools de lipides (par exemple glycérol, éthanolamine, sérine, choline, inositol), les lipides neutres (par exemple glycéride, diglycéride), les lipides complexes (par exemple lécithine, phosphatidyl sérine, phosphatidyl inositol, sphingolipides, cérébrosides), ou leurs mélanges. The lipids are chosen from the group comprising fats of plant or animal origin, fatty acids (for example palmitic acid, stearic acid, oleic acid, linoleic acid, linolenic acid, arachidonic acid), lipid alcohols (for example glycerol, ethanolamine). serine, choline, inositol), neutral lipids (eg glyceride, diglyceride), complex lipids (e.g. lecithin, phosphatidyl serine, phosphatidyl inositol, sphingolipids, cerebrosides), or mixtures thereof.
D'autres ingrédients actifs d'intérêt sont choisis parmi le L-carnitine, la glucosamine, le sulfate de chondroitine, l'ubiquinone, ou leurs mélanges. Other active ingredients of interest are selected from L-carnitine, glucosamine, chondroitin sulfate, ubiquinone, or mixtures thereof.
Selon une disposition de l'invention, la matrice pâteuse servant de base au complément alimentaire de l'invention comprend en outre un agent humidifiant, ou un agent de dilution,un agent émulsifiant, stabilisant et/ou gélifiant, un agent édulcorant, un agent révélateur de goût, un agent aromatisant alimentaire, un agent colorant alimentaire et/ou un agent d'enrobage. According to one provision of the invention, the pasty matrix serving as a base for the food supplement of the invention further comprises a moistening agent, or a diluting agent, an emulsifier, stabilizer and / or gelling agent, a sweetening agent, an agent taste developer, a food flavoring agent, a food coloring agent and / or a coating agent.
Comme agent humidifiant ou de dilution, on utilisera avantageusement de l'eau, l'agent édulcorant est par exemple un sucre naturel comme le glucose, le fructose, io le saccharose, le sorbitol, le xylitol et /ou un agent édulcorant artificiel, tel que par exemple l'aspartame, l'acésulfame, la saccharine ou autres du groupe E 900 à E 1520, ou leurs mélanges. As a moistening or dilution agent, it is advantageous to use water, the sweetening agent is, for example, a natural sugar such as glucose, fructose, sucrose, sorbitol, xylitol and / or an artificial sweetening agent, such as as for example aspartame, acesulfame, saccharin or others of the group E 900 to E 1520, or mixtures thereof.
Les ingrédients suivants peuvent encore être incorporés à la matrice pâteuse, par exemple les agents aromatisants alimentaires, comme les arômes alimentaires de fruits, naturels ou synthétiques, les agents colorants alimentaires choisis par exemple dans le groupe E100 à E180 et/ou les agents d'enrobage. The following ingredients may be further incorporated into the pasty matrix, for example food flavoring agents, such as fruit flavorings, natural or synthetic, food coloring agents selected for example from the group E100 to E180 and / or coating.
D'autres produits comprennent les agents conservateurs, choisis par exemple dans le groupe E200 à E 297, les agents anti-oxydants choisis notamment dans le groupe E300 à E 321, les agents émulsifiants, stabilisants et/ou gélifiants. Other products include preserving agents, chosen for example from the group E200 to E 297, the antioxidants chosen in particular from the group E300 to E 321, the emulsifying agents, stabilizers and / or gelling agents.
Les agents acidifiants ou alcalinisants sont choisis notamment dans le groupe E500 à E585, des révélateurs de goût choisis dans le groupe E600 à E 641, et des agents divers choisis dans le groupe E900 à El 520. The acidifying or alkalinizing agents are chosen in particular from the group E500 to E585, taste developers selected from the group E600 to E641, and various agents selected from the group E900 to E150.
Des compléments alimentaires préférés renferment environ de 10% à 70% en poids d'ingrédients actifs, c'est-à-dire à effet nutritionnel et/ou physiologique, par 25 rapport au poids total desdits compléments. Preferred dietary supplements contain from about 10% to 70% by weight of active ingredients, i.e., nutritional and / or physiological effect, based on the total weight of said supplements.
Complément alimentaire caractérisé en ce que la quantité des différents constituants de la formulation de base varie en particulier de 30% à 90% en poids par rapport au poids total dudit complément. Food supplement characterized in that the amount of the various constituents of the base formulation varies in particular from 30% to 90% by weight relative to the total weight of said complement.
De façon avantageuse, les ingrédients actifs présents dans le complément 30 alimentaire de l'invention n'ont subi aucune altération lors de la préparation dudit complément. Advantageously, the active ingredients present in the food supplement of the invention have not undergone any alteration during the preparation of said supplement.
En effet, conformément à l'invention, les matrices pâteuses de l'invention sont préparées dans un premier temps en chauffant des constituants utilisés jusqu'à une température n'excédant pas environ 60 C, et les ingrédients actifs y sont ajoutés en cours de refroidissement, de telle sorte qu'ils ne subissent aucune altération par la chaleur. Indeed, in accordance with the invention, the pasty matrices of the invention are first prepared by heating constituents used up to a temperature not exceeding about 60 ° C., and the active ingredients are added thereto during the course of the invention. cooling, so that they do not undergo any alteration by heat.
Les compléments alimentaires de la présente invention pourront par exemple être pris en association avec accompagnement des traitements spécifiques convenant pour les pathologies suivantes: maladies cardiovasculaires, maladies gastro-intestinales, maladies neurologiques, maladies infectieuses, maladies dermatologiques, maladies ostéo- articulaires, maladies métaboliques, maladies dégénératives, etc., cette liste n'étant cependant pas exhaustive. The food supplements of the present invention may for example be taken in combination with accompanying specific treatments suitable for the following pathologies: cardiovascular diseases, gastrointestinal diseases, neurological diseases, infectious diseases, dermatological diseases, osteoarticular diseases, metabolic diseases, degenerative diseases, etc., but this list is not exhaustive.
Des formulations préférées de complément alimentaire se présentent en portion io de 10 g, à mâcher, en emballage individuel. Le goût agréable des compléments facilite le bon suivi de leur prescription. Preferred dietary supplement formulations are in a 10 g portion, chewable, individually packaged. The pleasant taste of the supplements facilitates the good follow-up of their prescription.
Ces portions seront avantageusement prises en dehors des repas et en dehors des prises de médicaments. These portions will be advantageously taken outside of meals and outside the taking of drugs.
Les exemples suivants illustrent l'invention. Ils ne la limitent en aucune façon. The following examples illustrate the invention. They do not limit it in any way.
Exemple 1 - Complément alimentaire destiné à des sujets affectés par le syndrome d'intolérance au glucose ou d'un diabète de type 2. Example 1 - Dietary supplement for subjects affected by glucose intolerance syndrome or type 2 diabetes.
La composition d'un tel complément alimentaire comprend - un extrait de pépins de raisin, anti-oxydant puissant, 10-50 glkg, notamment 20 30 g/kg De la L-carnitine afin de prévenir la neuropathie 1- 20g/kg, notamment 15g/kg De la vitamine B12 pour prévenir la douleur neuropathique 0,1-0,5 mg/kg, notamment 0,3 mg/kg De la vitamine C pour prévenir la cataracte et la rétinopathie 3-20 g/kg, notamment 6 g/kg - De la vitamine E pour prévenir la rétinopathie 0,5-2 g/kg, notamment 1,2 g/kg Du magnésium pour corriger les déficits dus au diabète 10-50 g/kg, 30 notamment 30 g/kg Du chrome pour améliorer le métabolisme du sucre 5-15 mg/kg, notamment 12,5 mg/kg Du zinc pour protéger le gène récepteur de l'insuline de l'oxydation 0,2-1,5 g/kg, notamment 1,2 g/kg Des acides gras Omega 3 pour améliorer le métabolisme des lipides et protéger le système vasculaire 50-200 g/kg, notamment 100 g/kg dans une pâte de fruit composée de: Fructo-oligosaccharides de betterave, pour fournir des fibres, de la texture et de la douceur sans action de sécrétion de l'insuline, et pour augmenter l'immunité naturelle à travers leur activité pré-biotique spécifique, 50-200 g/kg, notamment 350 g/kg Fruit de Vaccinium myrtillus riche en anthocyanosides, sous la forme de jus concentré, un anti-oxydant puissant pour protéger le système vasculaire et io les yeux contre les réactions d'oxydation 20-200g/kg, notamment 150g/kg Gélatine (agent de gélification) 5-30 g/kg, notamment 20 g/kg Excipients: arôme, acide citrique, colorant qs Eau qs pour 100 portions présentant chacune un poids d'environ 10 g. The composition of such a dietary supplement comprises a grape seed extract, a powerful antioxidant, 10-50 g / kg, in particular 30 g / kg. L-carnitine to prevent neuropathy 1- 20 g / kg, in particular 15g / kg Vitamin B12 to prevent neuropathic pain 0.1-0.5 mg / kg, including 0.3 mg / kg Vitamin C to prevent cataract and retinopathy 3-20 g / kg, including 6 g / kg - Vitamin E to prevent retinopathy 0.5-2 g / kg, in particular 1.2 g / kg Magnesium to correct deficits due to diabetes 10-50 g / kg, in particular 30 g / kg Chromium to improve the metabolism of sugar 5-15 mg / kg, especially 12.5 mg / kg zinc to protect the insulin receptor gene from oxidation 0.2-1.5 g / kg, especially 1 , 2 g / kg Omega 3 fatty acids to improve lipid metabolism and protect the vascular system 50-200 g / kg, especially 100 g / kg in a fruit paste composed of: Beet fructo-oligosaccharides, for oven fiber, texture and softness without the secretory action of insulin, and to increase natural immunity through their specific pre-biotic activity, 50-200 g / kg, especially 350 g / kg Fruit of Vaccinium myrtillus rich in anthocyanosides, in the form of concentrated juice, a powerful antioxidant to protect the vascular system and the eyes against oxidation reactions 20-200 g / kg, especially 150 g / kg Gelatin (gelling agent) -30 g / kg, especially 20 g / kg Excipients: aroma, citric acid, color qs Water qs per 100 portions each having a weight of about 10 g.
La méthode d'administration du complément décrit ci-dessus est la suivante: Il pourra être conseillé, à chaque sujet recevant une prescription pour un traitement spécifique d'une maladie ou un régime pour cette même maladie, par un médecin et/ou un pharmacien et/ou un autre professionnel de santé, de prendre quotidiennement une portion du complément alimentaire tel que décrit ci-dessus, afin d'améliorer son équilibre général et son bien-être, et afin de réduire les risques de complications de sa maladie. The method of administration of the supplement described above is as follows: It may be advisable, for each subject receiving a prescription for a specific treatment of a disease or a diet for the same disease, by a doctor and / or a pharmacist and / or another health professional, to take a daily portion of the dietary supplement as described above, in order to improve his overall balance and well-being, and to reduce the risk of complications of his disease.
De préférence une portion du complément alimentaire tel que décrit cidessus sera prise régulièrement, en dehors de l'heure des repas ou des prises médicamenteuses, afin de bénéficier à long terme de l'activité des ingrédients rassemblés dans la matrice pâteuse, facile à mâcher et fondant dans la bouche. Preferably a portion of the dietary supplement as described above will be taken regularly, outside of mealtimes or drug intake, in order to benefit in the long term the activity of the ingredients gathered in the pasty matrix, easy to chew and melting in the mouth.
De façon avantageuse, le complément tel que ci-dessus décrit permet d'améliorer l'équilibre général et le bien-être des sujets affectés par un syndrome d'intolérance au glucose ou un diabète de type 2, et permet de réduire les risques de complications relatifs à leur maladie. Advantageously, the supplement as described above makes it possible to improve the general equilibrium and the well-being of the subjects affected by a syndrome of glucose intolerance or type 2 diabetes, and makes it possible to reduce the risks of complications related to their disease.
Exemple 2 - Complément alimentaire destiné à des sujets affectés par une maladie articulaire dégénérative telle que l'arthrose La composition d'un tel complément alimentaire comprend - Un extrait de Boswella serrata, 10-100 g/kg, notamment 50 g/kg pour son activité anti-inflammatoire - Un extrait de Camellia sinensis, 10-100 g/kg, notamment 50 glkg, pour prévenir la dégradation du cartilage, De la glucosamine, 10/100 glkg, notamment 50 g/kg, pour protéger le cartilage et réduire l'inflammation, Du sulfate de chondroitine, 101100 g/kg, notamment 50 g/kg, pour protéger le cartilage et réduire l'inflammation Des vitamines B3, B6, B9, B12, respectivement 0,5-2 mg/kg, notamment io 1,8 mg/kg, 0,1-0,3 mg/kg, notamment 0,2 mg/kg, 0,01-0,05 mg/kg, notamment 0,03 mg/kg et 0,01-0,05 mg/kg, notamment 0,3 mg/kg, pour contribuer à la réduction de l'inflammation, De la vitamine C (3-20 g/kg, notamment 6 g/kg) et de la vitamine E (0,5-2 g/kg, notamment 1,2 g/kg) pour limiter le stress oxydatif sur le cartilage et 15 réduire la douleur articulaire, De la vitamine D3 (0,5-2 mg/kg, notamment 1,5 mg/kg) pour réduire la dégradation du cartilage, Du manganèse (0,1-0,5 g/kg, notamment 0,2 g/kg) pour une activité optimale de la glucosamine, Du sélénium, 1-7 mg/kg, notamment 5 mg/kg, pour réduire le stress oxydatif sur le cartilage, Du zinc, 0,5-1,5 mg/kg, notamment 1,2 mg/kg, pour compenser les niveaux réduits trouvés dans le cartilage arthrosique, dans une matrice pâteuse composée de: Fructo-oligosaccharides de betterave, 100-800 g/kg, notamment 500 g/kg, pour fournir des fibres, de la texture et de la douceur et pour augmenter l'immunité naturelle à travers son activité pré-biotique spécifique, Concentré de tomates, 50-250 g/kg, notamment 100 g/kg, une source de lycopène anti-oxydant, - Gélatine, 5-30 g/kg, notamment 20 g/kg, agent de gélification Excipients: arôme, acide citrique, colorant qs Eau qs pour 100 portions présentant chacune un poids d'environ 10 g. Example 2 Food Supplement for Subjects Affected by a Degenerative Joint Disease such as Osteoarthritis The composition of such a dietary supplement comprises an extract of Boswella serrata, 10-100 g / kg, in particular 50 g / kg for its anti-inflammatory activity - an extract of Camellia sinensis, 10-100 g / kg, in particular 50 glkg, to prevent cartilage degradation, glucosamine, 10/100 glkg, especially 50 g / kg, to protect the cartilage and reduce inflammation, Chondroitin sulfate, 101100 g / kg, especially 50 g / kg, to protect the cartilage and reduce inflammation B3, B6, B9, B12 vitamins, respectively 0.5-2 mg / kg, especially 1.8 mg / kg, 0.1-0.3 mg / kg, in particular 0.2 mg / kg, 0.01-0.05 mg / kg, in particular 0.03 mg / kg and 0.01- 0.05 mg / kg, in particular 0.3 mg / kg, to contribute to the reduction of inflammation, vitamin C (3-20 g / kg, in particular 6 g / kg) and vitamin E (0 , 5-2 g / kg, in particular 1.2 g / kg) to limit stress oxidative on cartilage and reduce joint pain, vitamin D3 (0.5-2 mg / kg, especially 1.5 mg / kg) to reduce cartilage degradation, manganese (0.1-0.5 g / kg, especially 0.2 g / kg) for optimal glucosamine activity, selenium, 1-7 mg / kg, especially 5 mg / kg, to reduce oxidative stress on the cartilage, zinc, 0, 5-1.5 mg / kg, in particular 1.2 mg / kg, to compensate for the reduced levels found in osteoarthritic cartilage, in a pasty matrix composed of: Beet fructo-oligosaccharides, 100-800 g / kg, in particular 500 g / kg, to provide fiber, texture and softness and to increase natural immunity through its specific pre-biotic activity, tomato concentrate, 50-250 g / kg, especially 100 g / kg, a source of anti-oxidant lycopene, gelatin, 5-30 g / kg, in particular 20 g / kg, gelling agent Excipients: aroma, citric acid, color qs Water qs per 100 portions each having a weight of about 10 g.
2864426 io La méthode d'administration du complément décrit ci-dessus est la même que celle décrite dans l'exemple 1. Le complément permet d'améliorer l'équilibre général de l'organisme et le bien-être des sujets affectés l'arthrose et permet de réduire les risques de complications relatifs à leur maladie. The method of complement administration described above is the same as that described in Example 1. The supplement makes it possible to improve the general balance of the body and the well-being of the subjects affected by osteoarthritis. and reduces the risk of complications related to their disease.
Exemple 3 - Complément alimentaire destiné à des sujets affectés par une hyperlipidémie (= augmentation du taux de lipides circulant dans le sang) La composition d'un tel complément alimentaire comprend: L-arginine (antiathérogène, vasodilatateur) 2-20 g/kg, notamment 10g/kg io - Acides gras Omega 3 (protection cardio-vasculaire) 50-200 g/kg, notamment 100g/kg Extrait d'olivier (anti-oxydant) : 10-100 g/kg, notamment 50g/kg Extrait d'avoine (diminue le taux de triglycérides) 10-100 g/kg, notamment 50g/kg Extrait de Kola (diminue l'absorption des graisses) : 10-100 g/kg, notamment 50g/kg Vitamine B6: (diminue le taux d'homocystéine: lutte contre les complications cardio-vasculaires) : 0,1-0,3 g/kg, notamment 0, 2g/kg Vitamine B9 (diminue le taux d'homocystéine: lutte contre les complications cardio-vasculaires) : 0,01-0,05 g/kg, notamment 0,03g/kg Vitamine B12 (diminue le taux d'homocystéine: lutte contre les complications cardio-vasculaires) : 0,1-0,5 mg/kg, notamment 0.3mg/kg Vitamine C ( complémentaire de l'action de la L-arginine anti-oxydante) : 3-20 g/kg, notamment 6g/kg - Vitamine E ( diminue le taux de triglycérides) : 0,5-2 g/kg, notamment 1,2 g/kg - Magnésium (anti-stress contribue à lutter contre la constitution de plaques d'athérome) 10-50 g/kg, notamment 30g/kg dans une matrice pâteuse composée de: Fructo-oligosaccharides de betterave, 100-800 g/kg, notamment 450 g/kg, pour fournir des fibres, de la texture et de la douceur et pour augmenter l'immunité naturelle à travers son activité pré-biotique spécifique, Jus concentré de Kiwi, 50-250 g/kg, notamment 100 g/kg, (diminue l'absorption des lipides) 2864426 Il Jus concentré d'airelles 50-250 g/kg, notamment 100g/kg (diminue l'absorption des lipides) Gélatine, 5-30 g/kg, notamment 20 g/kg, agent de gélification Excipients: arôme, acide citrique, colorant qs - Eau qs pour 100 portions présentant chacune un poids d'environ 10 g. Example 3 - Dietary supplement for subjects affected by hyperlipidemia (= increase in the level of lipids circulating in the blood) The composition of such a dietary supplement comprises: L-arginine (antiatherogenic, vasodilator) 2-20 g / kg, especially 10 g / kg io - Omega 3 fatty acids (cardiovascular protection) 50-200 g / kg, in particular 100 g / kg Olive tree extract (antioxidant): 10-100 g / kg, in particular 50 g / kg oatmeal (decreases triglycerides) 10-100 g / kg, especially 50g / kg Kola extract (decreases fat absorption): 10-100 g / kg, especially 50g / kg Vitamin B6: (decreases the rate homocysteine: fight against cardiovascular complications): 0,1-0,3 g / kg, in particular 0, 2g / kg Vitamin B9 (decreases the level of homocysteine: fight against the cardiovascular complications): 0 , 01-0.05 g / kg, in particular 0.03 g / kg Vitamin B12 (decreases the level of homocysteine: fight against cardiovascular complications): 0.1-0.5 mg / kg, in particular 0.3 mg / kg Vitamin C (complementary to the action of L-arginine antioxidant): 3-20 g / kg, especially 6g / kg - Vitamin E (decreases the triglyceride level): 0.5-2 g / kg , in particular 1.2 g / kg - magnesium (anti-stress contributes to the fight against the constitution of atheroma plaques) 10-50 g / kg, in particular 30 g / kg in a pasty matrix composed of: beet fructo-oligosaccharides, 100-800 g / kg, especially 450 g / kg, to provide fiber, texture and softness and to increase natural immunity through its specific pre-biotic activity, Kiwi Juice Concentrate, 50-250 g / kg, in particular 100 g / kg, (decreases lipid absorption) 2864426 He Concentrated blueberry juice 50-250 g / kg, especially 100g / kg (decreases lipid absorption) Gelatin, 5-30 g / kg, in particular 20 g / kg, gelling agent Excipients: aroma, citric acid, dye qs - Water qs per 100 portions, each having a weight of approximately 10 g.
La méthode d'administration du complément décrit ci-dessus est la même que celle décrite dans l'exemple 1. Le complément permet d'améliorer l'équilibre général de l'organisme et le bien-être des sujets affectés d'hyperlipidémie et permet de io réduire les risques de complications relatifs à leur maladie. The method of administration of the complement described above is the same as that described in Example 1. The supplement makes it possible to improve the general balance of the body and the well-being of the subjects affected with hyperlipidemia and allows to reduce the risk of complications related to their disease.
Exemple 4 - Complément alimentaire destiné à des sujets affectés par une pathologie gastrique La composition d'un tel complément alimentaire comprend is un extrait de Griffonia (ré-équilibre l'humeur, anti-stress) 10 g/kg, notamment 50 g/kg un extrait d'Aspérule (sédatif nerveux, antistress) 10-100 g/kg, notamment 50 g/kg un extrait de réglisse déglycyrrhinisé (anti-ulcère, anti-saignements) 10-20 100 g/kg, notamment 50 g/kg un extrait de Pistacia lentiscus (aide à lutter contre les infections à helicobacter pylori) 10-100 g/kg, notamment 50 g/kg Glutamine (acide aminé participant à la santé de la muqueuse gastrique) - Vitamine A (effet anti-inflammatoire) 20-100 g/kg, notamment 40mg/kg Cuivre (contribue à la réparation de la muqueuse agressée) 50-300 g/kg, notamment 200mg/kg - Zinc (contribue à la réparation de la muqueuse agressée) 0,5-1,5 g/kg, notamment 1.2g/kg dans une matrice pâteuse composée de: Fructo- oligosaccharides de betterave, 100-800 g/kg, notamment 500 g/kg, pour fournir des fibres, de la texture et de la douceur et pour augmenter l'immunité naturelle à travers son activité pré-biotique spécifique, Concentré d'angélique, 50-250 g/kg, notamment 100 g/kg, (antiballonnements, anti-spasmes, stimule la digestion) - Gélatine, 20 g/kg 5-30, agent de gélification Excipients: arôme, acide citrique, colorant qs Eau qs pour 100 portions présentant chacune un poids d'environ 10 g. Example 4 Food Supplement for Subjects Affected by a Gastric Disease The composition of such a dietary supplement comprises is a Griffonia extract (re-equilibrium mood, anti-stress) 10 g / kg, in particular 50 g / kg an extract of Aspérule (nervous sedative, antistress) 10-100 g / kg, in particular 50 g / kg an extract of deglycyrrhinisé licorice (anti-ulcer, anti-bleeding) 10-20 100 g / kg, in particular 50 g / kg an extract of Pistacia lentiscus (helps to fight against Helicobacter pylori infections) 10-100 g / kg, in particular 50 g / kg Glutamine (amino acid participating in the health of the gastric mucosa) - Vitamin A (anti-inflammatory effect) 20-100 g / kg, in particular 40 mg / kg Copper (contributes to the repair of the attacked mucosa) 50-300 g / kg, in particular 200 mg / kg - Zinc (contributes to the repair of the attacked mucosa) 0.5-1 , 5 g / kg, in particular 1.2 g / kg in a pasty matrix composed of: beet fructo-oligosaccharides, 100-800 g / kg, in particular 500 g / kg, to provide fiber, texture and softness and to increase natural immunity through its specific pre-biotic activity, angelica concentrate, 50-250 g / kg, especially 100 g / kg. kg, (antiballooning, anti-spasm, stimulates digestion) - Gelatin, 20 g / kg 5-30, gelling agent Excipients: aroma, citric acid, color qs Water qs per 100 portions each having a weight of about 10 g .
La méthode d'administration du complément décrit ci-dessus est la même que 5 celle décrite dans l'exemple 1. Le complément permet d'améliorer l'équilibre général de l'organisme et le bien-être des sujets affectés d'une pathologie gastrique et permet de réduire les risques de complications relatifs à leur maladie. The method of complement administration described above is the same as that described in Example 1. The supplement makes it possible to improve the general balance of the body and the well-being of subjects suffering from a pathology. gastric and reduces the risk of complications related to their disease.
Exemple 5 - Complément alimentaire destiné à des sujets affectés par une to hypertension artérielle La composition d'un tel complément alimentaire comprend: Un extrait de cartilage de requin (contribue à diminuer la pression artérielle et le taux d'hormone parathyroïdienne) 10-100 g/kg, notamment 50 g/kg Un extrait de Berce spondyle (contribue à diminuer l'HTA et l'insuffisance rénale), 10-100 g/kg, notamment 50 g/kg Acides gras Omega 3 (protection cardio-vasculaire) 50-200 g/kg, notamment 100 g/kg L-arginine (acide aminé vasodilatateur, anti-athérogène et anti- adhésion plaquettaire) 5-50 g/kg, notamment 20g/kg Taurine ( dérivé anti- stress) 5-10 g/kg, notamment 20g/kg Ubiquinone (anti-oxydant stabilisant de membrane, augmente la résistance à l'effort et diminue l'ischémie) 1g/kg, notamment 5 g/kg - Vitamine B3 (anti-stress) 0,5-2 g/kg, notamment 1,8 g/kg - Vitamine B6: (diminue le taux d'homocystéine: lutte contre les complications cardio-vasculaires) 0,1-0,3 glkg, notamment 0,2 g/kg Vitamine B9 (diminue le taux d'homocystéine: lutte contre les complications cardio-vasculaires) 0,01-0,03 g/kg, notamment 0,03 g/kg Vitamine B12 (diminue le taux d'homocystéine: lutte contre les complications cardio-vasculaires) 0,1-0,5 mg/kg, notamment 0,3 mg/kg 3o Vitamine C (complémentaire de l'action de la L-arginine anti- oxydante) : 3-20 g/kg, notamment 6 g/kg - Vitamine E (diminue le taux de triglycérides) : 0,5-2 g/kg, notamment 1, 2 g/kg Magnésium (anti-stress contribue à lutter contre la constitution de plaques d'athérome) 10-50 g/kg, notamment 30 g/kg dans une matrice pâteuse composée de: Fructo-oligosaccharides de betterave, 100-800 g/kg, notamment 500 g/kg pour fournir des fibres, de la texture et de la douceur et pour augmenter l'immunité naturelle à travers son activité pré- biotique spécifique Jus concentré de mandarine, 50-250 g/kg, notamment 100 g/kg Pulpe de noix de coco 50-250 g/kg, notamment 100 g/kg Gélatine, 5-30 g/kg notamment 20 g/kg, agent de gélification Excipients: arôme, acide citrique, colorant qs Eau qs pour 100 portions présentant chacune un poids d'environ 10 g. Example 5 - Dietary Supplement for Subjects Affected by Arterial Hypertension The composition of such a dietary supplement includes: A shark cartilage extract (contributes to lowering blood pressure and parathyroid hormone level) 10-100 g / kg, in particular 50 g / kg An extract of Berce Spondyle (contributes to decrease the HTA and the renal insufficiency), 10-100 g / kg, in particular 50 g / kg Fatty acids Omega 3 (cardiovascular protection) 50 -200 g / kg, in particular 100 g / kg L-arginine (vasodilator amino acid, anti-atherogenic and anti-platelet adhesion) 5-50 g / kg, in particular 20 g / kg Taurine (anti-stress derivative) 5-10 g / kg, especially 20g / kg Ubiquinone (stabilizing membrane antioxidant, increases resistance to exercise and decreases ischemia) 1g / kg, especially 5g / kg - Vitamin B3 (anti-stress) 0.5- 2 g / kg, in particular 1.8 g / kg - Vitamin B6: (decreases the level of homocysteine: fight against cardiovascular complications) 0.1-0.3 glk g, in particular 0.2 g / kg Vitamin B9 (decreases the level of homocysteine: fight against cardiovascular complications) 0.01-0.03 g / kg, in particular 0.03 g / kg Vitamin B12 (decreases the homocysteine level: fight against cardiovascular complications) 0.1-0.5 mg / kg, in particular 0.3 mg / kg 3o Vitamin C (complementary to the action of L-arginine antioxidant): 3-20 g / kg, especially 6 g / kg - Vitamin E (decreases the triglyceride level): 0.5-2 g / kg, in particular 1, 2 g / kg Magnesium (anti-stress contributes to fight against the constitution 10-50 g / kg, in particular 30 g / kg in a pasty matrix composed of: beet fructo-oligosaccharides, 100-800 g / kg, in particular 500 g / kg to provide fibers, texture and softness and to increase natural immunity through its specific pre-biotic activity Concentrated tangerine juice, 50-250 g / kg, especially 100 g / kg coconut pulp 50-250 g / kg, especially 100 g / kg Gelatin, 5-30 g / kg 20 g / kg, gelling agent Excipients: aroma, citric acid, color qs Water qs per 100 portions each having a weight of about 10 g.
La méthode d'administration du complément décrit ci-dessus est la même que celle décrite dans l'exemple 1. Le complément permet d'améliorer l'équilibre général de l'organisme et le bien-être des sujets affectés d'une pathologie gastrique et permet de réduire les risques de complications relatifs à leur maladie. The method of administration of the complement described above is the same as that described in Example 1. The supplement makes it possible to improve the general equilibrium of the organism and the well-being of subjects suffering from a gastric pathology. and reduces the risk of complications related to their disease.
Exemple 6 - Complément alimentaire destiné à des sujets traités parantibiothérapie pour une infection bactérienne La composition d'un tel complément alimentaire comprend - Un extrait de Thym (anti-mycosique) 10 g/kg, notamment 50 g/kg Un extrait de Sauge (anti-mycosique) 10-100 g/kg, notamment 50 g/kg - Un extrait de Shitaké (stimulant de l'immunité naturelle) 10-100 g/kg, notamment 50 g/kg - Un extrait de Camomille (anti-mycosique) 10-100 g/kg, notamment 50 g/kg Un extrait de gingembre (anti-mycosique, anti-oxydant) 10-100 g/kg, notamment 50 g/kg - Vitamine B3 (effet anti-inflammatoire) 0,5-3 g/kg, notamment 1,8 g/kg - Manganèse (lutte contre les infections) 100-600 mg/kg, notamment 30 400 mg/kg Zinc (lutte contre les infections) 0,5-1,5 g/kg, notamment 1,2 g/kg Cuivre (lutte contre les infections) 50-300 g/kg, notamment 200 mg/kg dans une matrice pâteuse composée de: Fructo-oligosaccharides de betterave, 100-800 g/kg, notamment 500 g/kg, pour fournir des fibres, de la texture et de la douceur sans action de sécrétion de l'insuline, et pour augmenter l'immunité naturelle à travers son activité pré-biotique spécifique, Jus concentré goyave, 50-250 g/kg, notamment 100 g/kg, (anti- diarrhéique, anti-mycosique) Gélatine, 5-30 g/kg, notamment 20 g/kg, agent de gélification Excipients: arôme, acide citrique, colorant qs Eau qs pour 100 portions présentant chacune un poids d'environ 10 g. Example 6 Food Supplement for Subjects Treated with Antibiotic Therapy for a Bacterial Infection The composition of such a dietary supplement comprises: An extract of thyme (anti-mycotic) 10 g / kg, in particular 50 g / kg Sage extract (anti-fungal) -mycotic) 10-100 g / kg, especially 50 g / kg - Shitake extract (natural immunity stimulant) 10-100 g / kg, especially 50 g / kg - Chamomile extract (anti-mycotic) 10-100 g / kg, in particular 50 g / kg A ginger extract (anti-mycotic, anti-oxidant) 10-100 g / kg, in particular 50 g / kg - Vitamin B3 (anti-inflammatory effect) 0.5- 3 g / kg, in particular 1.8 g / kg - Manganese (infection control) 100-600 mg / kg, in particular 30 400 mg / kg Zinc (infection control) 0.5-1.5 g / kg , in particular 1.2 g / kg Copper (infection control) 50-300 g / kg, in particular 200 mg / kg in a pasty matrix composed of: Beet fructo-oligosaccharides, 100-800 g / kg, in particular 500 g / kg, to provide fibers, tex ture and softness without the secretory action of insulin, and to increase natural immunity through its specific pre-biotic activity, Guava concentrated juice, 50-250 g / kg, especially 100 g / kg, (anti- diarrheal, anti-mycotic) Gelatin, 5-30 g / kg, in particular 20 g / kg, gelling agent Excipients: aroma, citric acid, color qs Water qs per 100 portions each having a weight of about 10 g.
La méthode d'administration du complément décrit ci-dessus est la même que celle décrite dans l'exemple 1. Le complément permet d'améliorer l'équilibre général de l'organisme et le bien-être des sujets traités par antibiotiques pour une infection bactérienne et permet de réduire les risques de complications relatifs à leur maladie. The method of administration of the complement described above is the same as that described in Example 1. The supplement makes it possible to improve the general balance of the body and the well-being of the subjects treated with antibiotics for an infection. bacterial and reduces the risk of complications related to their disease.
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0315534A FR2864426A1 (en) | 2003-12-29 | 2003-12-29 | Food supplement designed to make up for nutritional deficiencies comprises paste matrix with added extracts of fruit, vegetable or animal origin, vitamins and minerals |
PCT/FR2004/003404 WO2005067737A1 (en) | 2003-12-29 | 2004-12-29 | Food additive for compensating nutrition deficit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0315534A FR2864426A1 (en) | 2003-12-29 | 2003-12-29 | Food supplement designed to make up for nutritional deficiencies comprises paste matrix with added extracts of fruit, vegetable or animal origin, vitamins and minerals |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2864426A1 true FR2864426A1 (en) | 2005-07-01 |
Family
ID=34639678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0315534A Withdrawn FR2864426A1 (en) | 2003-12-29 | 2003-12-29 | Food supplement designed to make up for nutritional deficiencies comprises paste matrix with added extracts of fruit, vegetable or animal origin, vitamins and minerals |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2864426A1 (en) |
WO (1) | WO2005067737A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010000877A2 (en) * | 2009-10-14 | 2010-01-07 | Symrise Gmbh & Co. Kg | Formulation with irritation reducing action comprising bisabolol and [6]-paradol |
ITMI20081478A1 (en) * | 2008-08-06 | 2010-02-07 | Moldes S R L | FORMULATION OF AQUEOUS GEL FOR THE ADMINISTRATION OF PHARMACEUTICAL AND / OR NUTRITIONAL SUBSTANCES |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778676A (en) * | 1985-12-20 | 1988-10-18 | Warner-Lambert Company | Confectionery delivery system for actives |
JPH0965855A (en) * | 1995-08-28 | 1997-03-11 | Otsuka Shokuhin Kk | Low-caloric food material for controlling intestinal function |
WO1997023201A1 (en) * | 1995-12-26 | 1997-07-03 | Onesta Nutrition, Inc. | Dietary fiber delivery system |
US5965162A (en) * | 1993-09-10 | 1999-10-12 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
WO1999053777A1 (en) * | 1998-04-22 | 1999-10-28 | Novartis Nutrition Ag | Nutritional supplement for pregnant and lactating women |
DE10008990A1 (en) * | 2000-01-11 | 2001-07-12 | Vitafood Ag St Gallen | Milk-free, oligofructose-containing prebiotic instant powder for use as a food supplement or in drink production also contains minerals, trace elements or plant extracts |
DE10008279A1 (en) * | 2000-02-23 | 2001-08-30 | Meggle Gmbh | Synergistic medicinal or health-promoting food additive composition, comprising lactose, inulin and/or oligofructose, calcium salt and Bifidus bacteria, having e.g. immunostimulant and digestion improving action |
US20010036468A1 (en) * | 1998-07-25 | 2001-11-01 | Sam-A-Pharmaceuticals Co., Ltd. | Soft chewable multivitamin tablet comprising separated active ingredients |
US6468568B1 (en) * | 2000-06-16 | 2002-10-22 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
US20020172724A1 (en) * | 1999-07-30 | 2002-11-21 | Forusz Samuel L. | Composition for increasing bone density |
US20020197372A1 (en) * | 1999-12-17 | 2002-12-26 | Evelyn Janssen | Solid mixture consisting of foodstuff ingredients and foodstuff additives, method for the production thereof and their use |
-
2003
- 2003-12-29 FR FR0315534A patent/FR2864426A1/en not_active Withdrawn
-
2004
- 2004-12-29 WO PCT/FR2004/003404 patent/WO2005067737A1/en active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4778676A (en) * | 1985-12-20 | 1988-10-18 | Warner-Lambert Company | Confectionery delivery system for actives |
US5965162A (en) * | 1993-09-10 | 1999-10-12 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom |
JPH0965855A (en) * | 1995-08-28 | 1997-03-11 | Otsuka Shokuhin Kk | Low-caloric food material for controlling intestinal function |
WO1997023201A1 (en) * | 1995-12-26 | 1997-07-03 | Onesta Nutrition, Inc. | Dietary fiber delivery system |
WO1999053777A1 (en) * | 1998-04-22 | 1999-10-28 | Novartis Nutrition Ag | Nutritional supplement for pregnant and lactating women |
US20010036468A1 (en) * | 1998-07-25 | 2001-11-01 | Sam-A-Pharmaceuticals Co., Ltd. | Soft chewable multivitamin tablet comprising separated active ingredients |
US20020172724A1 (en) * | 1999-07-30 | 2002-11-21 | Forusz Samuel L. | Composition for increasing bone density |
US20020197372A1 (en) * | 1999-12-17 | 2002-12-26 | Evelyn Janssen | Solid mixture consisting of foodstuff ingredients and foodstuff additives, method for the production thereof and their use |
DE10008990A1 (en) * | 2000-01-11 | 2001-07-12 | Vitafood Ag St Gallen | Milk-free, oligofructose-containing prebiotic instant powder for use as a food supplement or in drink production also contains minerals, trace elements or plant extracts |
DE10008279A1 (en) * | 2000-02-23 | 2001-08-30 | Meggle Gmbh | Synergistic medicinal or health-promoting food additive composition, comprising lactose, inulin and/or oligofructose, calcium salt and Bifidus bacteria, having e.g. immunostimulant and digestion improving action |
US6468568B1 (en) * | 2000-06-16 | 2002-10-22 | General Mills, Inc. | Oligosaccharide encapsulated mineral and vitamin ingredients |
Non-Patent Citations (3)
Title |
---|
DATABASE FSTA [online] INTERNATIONAL FOOD INFORMATION SERVICE (IFIS), FRANkFURT-MAIN, DE; IN-CHEOL KIM: "Manufacture of citron jelly using the citron-extract.", XP002291820, Database accession no. 1999-00-j2336 * |
DATABASE WPI Section Ch Week 199720, Derwent World Patents Index; Class B04, AN 1997-220392, XP002291821 * |
IN-CHEOL KIM, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 28, no. 2, 1999, pages 396 - 402 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20081478A1 (en) * | 2008-08-06 | 2010-02-07 | Moldes S R L | FORMULATION OF AQUEOUS GEL FOR THE ADMINISTRATION OF PHARMACEUTICAL AND / OR NUTRITIONAL SUBSTANCES |
WO2010000877A2 (en) * | 2009-10-14 | 2010-01-07 | Symrise Gmbh & Co. Kg | Formulation with irritation reducing action comprising bisabolol and [6]-paradol |
WO2010000877A3 (en) * | 2009-10-14 | 2010-10-21 | Symrise Gmbh & Co. Kg | Formulation with irritation reducing action comprising bisabolol and [6]-paradol |
US8951507B2 (en) | 2009-10-14 | 2015-02-10 | Symrise Ag | Formulation with irritation reducing action comprising bisabolol and [6]-paradol |
Also Published As
Publication number | Publication date |
---|---|
WO2005067737A1 (en) | 2005-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7445807B2 (en) | Agglomerated granular protein-rich nutritional supplement | |
US6638542B2 (en) | Reducing appetite in mammals by administering procyanidin and hydroxycitric acid | |
US20230132388A9 (en) | Intact Pea Protein-Based Nutrient Composition | |
CN106072573A (en) | A kind of it is applicable to the special dietary seafood that old aged muscle decay disease is edible | |
US20060263459A1 (en) | Sea Buckthorn Compositions and Associated Methods | |
JP2007501852A (en) | Diet food for weight control or weight loss diet | |
US20210045423A1 (en) | Hydrolyzed Pea Protein-Based Nutrient Composition | |
CN109152749A (en) | For treating or preventing the impaired alimentation composition of mobility | |
CN104839688A (en) | Eye care preparation and preparation method thereof | |
EP2859896B1 (en) | Pharmaceutical compositions for the treatment of muscular disorders | |
US10653655B2 (en) | Composition for preventing or improving peripheral neuropathy | |
TW201434470A (en) | Nutritional compositions and methods for enhancing cognitive function and muscle function | |
US20200113982A1 (en) | Composition and Uses Thereof | |
WO2008140064A1 (en) | Nutrient composition for prevention and amelioration of lifestyle-related disease | |
CA3113821A1 (en) | Leucine-enriched ketogenic formulations | |
FR2864426A1 (en) | Food supplement designed to make up for nutritional deficiencies comprises paste matrix with added extracts of fruit, vegetable or animal origin, vitamins and minerals | |
JP2007330191A (en) | Food suppressing maillard reaction | |
FR3036961A1 (en) | FOOD SUPPLEMENT COMPRISING A MIXTURE OF MAGNESIUM OXIDE AND MAGNESIUM CARBONATE | |
JP2012065607A (en) | Supplement | |
WO2016135482A1 (en) | Compositions comprising co-q10, krill oil and vitamin d | |
RU2616399C1 (en) | Method for producing biologically active product for adaptive feeding and biologically active product for adaptive feeding | |
JP2006505592A (en) | Increased sexual desire and function by powders from plants containing protein-bound tryptophan | |
WO2022200334A1 (en) | Nutraceutical composition comprising inulin for treating and preventing ocular disorders or intestinal microbiota imbalance | |
IT201900007002A1 (en) | COFFEE-BASED FOOD SUPPLEMENT | |
Janson | Stop Aging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20081020 |